Suchergebnisse - "Corso, Alessandro"

PubPharm (5)

1

Pomalidomide, bortezomib, and dexamethasone for multiple myeloma previously treated with lenalidomide (OPTIMISMM) : outcomes by prior treatment at first relapse

enthalten in: Leukemia | 2021

von Dimopoulos, M. | Weisel, K. | Moreau, P. | +17

2

Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM) : a randomised, open-label, phase 3 trial

enthalten in: The Lancet. Oncology | 2019

von Richardson, P. | Oriol, A. | Beksac, M. | +123

CommentIn: Lancet Oncol. 2019 Jun;20(6):743-744. - PMID 31097404

3

Multiple Myeloma Treatment in Real-world Clinical Practice : Results of a Prospective, Multinational, Noninterventional Study

enthalten in: Clinical lymphoma, myeloma & leukemia | 2018

von Mohty, M. | Terpos, E. | Mateos, M. | +130

4

Continuous lenalidomide treatment for newly diagnosed multiple myeloma

enthalten in: The New England journal of medicine | 2012

von Palumbo, A. | Hajek, R. | Delforge, M. | +86

ErratumIn: N Engl J Med. 2012 Jul 19;367(3):285

5

Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma

enthalten in: The New England journal of medicine | 2007

von Dimopoulos, M. | Spencer, A. | Attal, M. | +15

ErratumIn: N Engl J Med. 2009 Jul 30;361(5):544

1
[1]